Coder Megan, McBride Lacey, McClenahan Samantha
Digital Medicine Society (DiMe), Boston, MA, USA.
NPJ Digit Med. 2024 Aug 13;7(1):212. doi: 10.1038/s41746-024-01209-2.
Digital health technologies (DHT) offer the ability to deliver personalized care, lower barriers to access, and positively impact health outcomes. However, DHT utilization is impacted by insufficient market access pathways. A policy “full-stack”—including regulatory authorization, product value assessment, pricing and reimbursement, and patient access infrastructure—offers a framework for DHT integration into national healthcare ecosystems. Consistent clinical evidence requirements across national jurisdictions will further increase DHT scalability.
数字健康技术（DHT）能够提供个性化护理，降低获取医疗服务的障碍，并对健康结果产生积极影响。然而，DHT的应用受到市场准入途径不足的影响。一项包括监管授权、产品价值评估、定价与报销以及患者获取基础设施的政策“全栈式方案”，为DHT融入国家医疗生态系统提供了一个框架。各国司法管辖区统一的临床证据要求将进一步提高DHT的可扩展性。
